On 7/19/24, MediWound Ltd (NASDAQ: MDWD) stock suffered a major decline of -11.0%, closing at $18.60. This decline was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -7.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, MDWD is expected to be Value Creation neutral.
MediWound has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. MediWound has a very low Appreciation Score of 5 but a very high Power Rating of 89, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment